Study of HRS9531 for weight loss in overweight or obese adults
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests an oral medication, HRS9531, to help overweight or obese adults lose weight. It may be an option if you have been unable to lose enough weight through diet and exercise alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- Your body mass index (BMI) is 28 or higher, or 24 or higher with a weight-related health condition like high blood pressure or high cholesterol.
- You have been following a diet and exercise plan for at least 3 months, with no more than a 5% change in weight during that time.
- You do not have certain serious health conditions like uncontrolled high blood pressure, diabetes, or a history of weight-loss surgery.
- You are not currently using any medications or treatments that have caused significant weight change in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two versions of the study drug HRS9531 in people with overweight or obesity to see which one works better in the body. It may help find a more effective treatment for weight management.
This study tests a new weight-loss medicine called HRS-1596. It is given as a tablet to see if it is safe and how well it works. The study first gives a single dose to healthy adults, then multiple doses to people with obesity.
This study tests the safety of a new oral medication called HRS-1597 in two groups: healthy people with normal weight and people who are overweight or obese. It will help determine if the drug is safe and how the body processes it.
This study tests a new medication called HRS-7535 for people who have high blood pressure and are also overweight or obese. The drug may help lower blood pressure and support weight loss, and this trial will compare it to a placebo to see if it works well and is safe.
This study tests how a new tablet (called HRS9531) is absorbed and processed by the body under different conditions (like with or without food). It is for healthy volunteers to find the best way to take the tablet.
This trial tests an injectable medication (HRS9531) to see if it helps people with both obstructive sleep apnea and obesity. It compares the drug to a placebo (no active medicine) to check safety and effectiveness.
Hear when a new Chronic Management of Body Weight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.